Lundbeck makes huge bid for Longboard

Danish Lundbeck has made a bid for American Longboard Pharmaceuticals worth USD 2.6 billion. With this deal, they would get access to Bexicaserin, a promising treatment for severe epilepsy syndromes. Lundbeck shares are rising on the news.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/10/lundbeck-makes-huge-bid-for-longboard/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se